MOLECULAR MECHANISM OF DYSKERATOSIS CONGENITA
先天性角化不良的分子机制
基本信息
- 批准号:7474615
- 负责人:
- 金额:$ 39.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-09-30 至 2010-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinityAffinity ChromatographyBiological AssayCell ExtractsCell physiologyCellsClassComplexCore ProteinDiseaseDyskeratosis CongenitaEnzymesEvaluationEventGenesHomologous GeneIn VitroIndividualKnowledgeMapsMediatingModelingMolecularMutationNAP57NuclearNuclear ExtractNucleosome Core ParticlePancytopeniaPatientsPlayPositioning AttributeProteinsRNARNA ProcessingRecombinant ProteinsRecombinantsRelative (related person)RibonucleoproteinsRibosomal RNARoleSiteSite-Directed MutagenesisSmall Nuclear RNASmall Nucleolar RNASmall Nucleolar RibonucleoproteinsStructureSurfaceSyndromeSystemTelomerase RNA ComponentTestingX-Linked Dyskeratosis Congenitabasecomparativedrug developmentin vitro Assayin vivoinsightmutantparticleprotein structurereconstitutionsmall moleculethree dimensional structure
项目摘要
DESCRIPTION (provided by applicant):
X-linked dyskeratosis congenita (DC) is caused by mutations in DKC1, the gene encoding NAP57 (aka dyskerin). DC is an often-fatal bone marrow failure syndrome and a complex multi-system disorder. NAP57 together with three other core proteins associates with one hundred or so different small nuclear RNAs (snRNAs) characterized by H and ACA motifs to form as many ribonucleoprotein particles (RNPs). These H/ACA RNPs function in at least four distinct nuclear events, ribosomal RNA (rRNA) pseudouridylation, pre-rRNA processing, spliceosomal snRNA pseudouridylation, and telomerase RNA stabilization. NAP57 functions as the pseudouridylase and is required for the integrity of H/ACA RNPs. We established an in vitro assay for snoRNP-mediated pseudouridylation and resolved an assembly map for core H/ACA RNPs. We hypothesize that mutations in NAP57 not only affect NAP57 itself but also the entire H/ACA RNP and its function(s). Here we will test this hypothesis by, first, establishing a detailed structure-function map of NAP57 and H/ACA RNPs and, second, by determining the impact of DC mutations. This will be approached in the following four Specific Aims: (1) assembly and comparison of the four functional classes of H/ACA RNPs by affinity purification via tagged H/ACA RNAs of H/ACA RNPs assembled in cell extracts; (2) reconstitution of H/ACA RNPs with wild type and mutant NAP57 from purified recombinant components and analysis of their interactions; (3) modeling of the three-dimensional structure of NAP57 based on the known structure of bacterial homologs and prediction of the impact of DC mutations; and (4) evaluation of structure and function of H/ACA RNPs in patient cells. The results of this application will allow pinpointing the molecular consequences of DC mutations on several basic cellular functions and thereby provide the basis for small molecule/drug development.
描述(由申请人提供):
X连锁先天性角化不良(DC)是由编码NAP 57(又名dyskerin)的基因DKC 1突变引起的。DC是一种经常致命的骨髓衰竭综合征,是一种复杂的多系统疾病。NAP 57与其他三种核心蛋白一起与大约100种不同的小核RNA(snRNA)结合,其特征在于H和ACA基序,以形成尽可能多的核糖核蛋白颗粒(RNP)。这些H/ACA RNP在至少四个不同的核事件中起作用,核糖体RNA(rRNA)假尿苷化、前rRNA加工、剪接体snRNA假尿苷化和端粒酶RNA稳定化。NAP 57作为假尿苷酶起作用,并且是H/ACA RNP的完整性所需的。我们建立了一个体外测定snoRNP介导的假尿苷化,并解决了核心H/ACA RNP的装配图。我们假设NAP 57中的突变不仅影响NAP 57本身,而且影响整个H/ACA RNP及其功能。在这里,我们将测试这一假设,首先,建立一个详细的结构-功能图谱的NAP 57和H/ACA RNP,其次,通过确定DC突变的影响。本研究的主要目的是:(1)通过亲和纯化的方法,从细胞提取物中组装的H/ACA RNP中标记H/ACA RNA,组装并比较四种功能类型的H/ACA RNP;(2)从纯化的重组组分中重组H/ACA RNP,并分析它们与野生型和突变型NAP 57的相互作用;(3)基于细菌同源物的已知结构的NAP 57的三维结构的建模和DC突变的影响的预测;和(4)患者细胞中H/ACA RNP的结构和功能的评估。该应用的结果将允许精确定位DC突变对几种基本细胞功能的分子后果,从而为小分子/药物开发提供基础。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Stepwise RNP assembly at the site of H/ACA RNA transcription in human cells.
- DOI:10.1083/jcb.200601105
- 发表时间:2006-04-24
- 期刊:
- 影响因子:0
- 作者:Darzacq X;Kittur N;Roy S;Shav-Tal Y;Singer RH;Meier UT
- 通讯作者:Meier UT
Localization of Nopp140 within mammalian cells during interphase and mitosis.
- DOI:10.1007/s00418-009-0599-8
- 发表时间:2009-08
- 期刊:
- 影响因子:2.3
- 作者:Thiry, Marc;Cheutin, Thierry;Lamaye, Francoise;Thelen, Nicolas;Meier, U. Thomas;O'Donohue, Marie-Francoise;Ploton, Dominique
- 通讯作者:Ploton, Dominique
Distant positioning of proteasomal proteolysis relative to actively transcribed genes.
- DOI:10.1093/nar/gkr069
- 发表时间:2011-06
- 期刊:
- 影响因子:14.9
- 作者:Scharf A;Grozdanov PN;Veith R;Kubitscheck U;Meier UT;von Mikecz A
- 通讯作者:von Mikecz A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
U THOMAS MEIER其他文献
U THOMAS MEIER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('U THOMAS MEIER', 18)}}的其他基金
Cellular impact of X-linked dyskeratosis congenita
X连锁先天性角化不良的细胞影响
- 批准号:
9861050 - 财政年份:2017
- 资助金额:
$ 39.35万 - 项目类别:
Cellular impact of X-linked dyskeratosis congenita
X连锁先天性角化不良的细胞影响
- 批准号:
9545059 - 财政年份:2017
- 资助金额:
$ 39.35万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 39.35万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 39.35万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 39.35万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 39.35万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 39.35万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 39.35万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 39.35万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 39.35万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 39.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 39.35万 - 项目类别:
Collaborative Research and Development Grants